You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國際醫學(000516.SZ):545名員工響應實控人倡議共增持443.3318萬股、增持均價為11.58元/股
格隆匯 10-11 16:40

格隆匯10月11日丨國際醫學(000516.SZ)公佈,截止2022年10月11日,公司實際控制人倡議公司員工在倡議增持期間增持國際醫學股票後連續持有的時間已滿12個月。

公司對公司及全資子公司、控股子公司的員工在2021年9月17日至10月11日增持公司股票的情況進行了詳細的統計,增持員工人數545人,增持股票總金額約5134.71萬元,增持股票數量443.3318萬股,增持股票平均價格11.58元/股。

此次倡議涉及的增持主體為公司和公司的全資子公司及控股子公司的全體員工;增持期間為2021年9月17日至2021年10月11日;上述增持主體若在增持期限內通過員工本人證券賬户淨買入的公司股票,連續持有12個月,至2022年10月11日當日收盤後(即增持期限12個月後的第一個交易日,如公司發生重大事項停牌等事宜導致公司股票無法交易的,則該日期順延),並且本人繼續為公司在職員工的,如該部分公司股票市值低於其投資成本,則投資成本與當日收盤後股票市值的差額,在員工個人提交書面補償申請及國際醫學股票交易對賬單後,由實際控制人劉建申先生或其指定的下屬公司在2022年10月11日收市後一個月內以自有資金予以補償。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account